• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (HR 2410, 115th Congress)

The Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (HR 2410) is designed to reauthorize expired federal sickle cell disease programs and establish new federal sickle cell disease research, surveillance, prevention, and treatment programs.

HR 2410 amends section 399V of title III of the Public Health Service Act (42 U.S.C. 280g-11 et seq.) to authorize the Department of Health and Human Services to undertake the following research and surveillance efforts:

  • Establish research efforts to explore causes and cures for the disease.
  • Award grants to entities in up to 20 states that demonstrate collaboration with other communal organizations and healthcare providers to:
    -Collect data on the prevalence and demographics of sickle cell disease
    -Organize public health initiatives
    -Research potential prevention and treatment strategies

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.